A doseranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: The Einstein-dvt dose-ranging study - Buller, HR; Lensing, AW; Prins, MH (Blood, 2008)
et al.